Should the beneficial impact of bezafibrate on fatty acid oxidation disorders be questioned?
Crossref DOI link: https://doi.org/10.1007/s10545-014-9775-7
Published Online: 2014-10-14
Published Print: 2015-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Bastin, Jean
Bonnefont, Jean‐Paul
Djouadi, Fatima
Bresson, Jean‐Louis
Version of Record valid from 2014-10-14